REGENERATIVE MEDICINE CROSSING BORDERS

On 15 November, a Letter of Commitment was signed by the partners of RegMed XB to confirm their (financial) commitment in a plan to develop affordable therapies for four chronic diseases.
On November 5th 2018, a Memorandum of Understanding featuring RegMed XB was signed by State Secretary Mona Keijzer of EZK and Minister Phillipe Muyters of EWI in the presence of both the Dutch and Flemish Prime Ministers. For RegMed XB, this memorandum can be seen as a step towards establishing an industrial platform for regenerative medicine
RegMed XB discusses with Massachusetts Life Sciences Center and the Wyss Institute. With a symposium on 24 and 25 October, Dutch representatives of RegMed XB celebrated the World Launch in Boston with esteemed American colleagues, administrators, scientists and companies.
Scientists and physicians from the universities and involved institutes of Utrecht, Maastricht, Leiden and Eindhoven will be working together.
Scientists and physicians from the universities and involved institutes of Utrecht, Maastricht, Leiden and Eindhoven will be working together. Photograph courtesy of 4bluecells.com.

A robust new institute for regenerative medicine

Regenerative medicine aims to restore degenerated, diseased or damaged tissues and organs, thereby increasing vital functioning and reducing the cost of healthcare. RegMed XB brings together multiple health foundations, top scientists, entrepreneurs and governments to cooperatively tackle ambitious challenges in regenerative medicine. In RegMed XB, research and clinical translation are integrated to quickly and optimally bring research results into patient solutions and new businesses.

A robust new institute for regenerative medicine

Recent news